JP2004514002A - 新規ポリエステル、その製法および前記ポリエステルから製造されるデポー剤 - Google Patents

新規ポリエステル、その製法および前記ポリエステルから製造されるデポー剤 Download PDF

Info

Publication number
JP2004514002A
JP2004514002A JP2002541975A JP2002541975A JP2004514002A JP 2004514002 A JP2004514002 A JP 2004514002A JP 2002541975 A JP2002541975 A JP 2002541975A JP 2002541975 A JP2002541975 A JP 2002541975A JP 2004514002 A JP2004514002 A JP 2004514002A
Authority
JP
Japan
Prior art keywords
polyester
extruder
electrolyte
hydroxycarboxylic acid
resorbable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002541975A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004514002A5 (enExample
Inventor
ユクシン　リ
デトレフ　モア
ティム　ザイフェルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma AG filed Critical Schwarz Pharma AG
Publication of JP2004514002A publication Critical patent/JP2004514002A/ja
Publication of JP2004514002A5 publication Critical patent/JP2004514002A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C08G63/82—Preparation processes characterised by the catalyst used
    • C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2002541975A 2000-11-10 2001-11-08 新規ポリエステル、その製法および前記ポリエステルから製造されるデポー剤 Pending JP2004514002A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10055742A DE10055742B4 (de) 2000-11-10 2000-11-10 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen
PCT/EP2001/012888 WO2002038646A2 (de) 2000-11-10 2001-11-08 Neue polyester, verfahren zu ihrer herstellung und aus den polyestern hergestellte depot-arzneiformen

Publications (2)

Publication Number Publication Date
JP2004514002A true JP2004514002A (ja) 2004-05-13
JP2004514002A5 JP2004514002A5 (enExample) 2005-05-26

Family

ID=7662818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002541975A Pending JP2004514002A (ja) 2000-11-10 2001-11-08 新規ポリエステル、その製法および前記ポリエステルから製造されるデポー剤

Country Status (8)

Country Link
US (1) US7087247B2 (enExample)
EP (1) EP1345979B1 (enExample)
JP (1) JP2004514002A (enExample)
AT (1) ATE271083T1 (enExample)
AU (1) AU2002229539A1 (enExample)
DE (2) DE10055742B4 (enExample)
ES (1) ES2225636T3 (enExample)
WO (1) WO2002038646A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008513524A (ja) * 2004-09-21 2008-05-01 山▲東緑▼叶制▲薬▼有限公司 ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法
WO2024166833A1 (ja) * 2023-02-08 2024-08-15 Ｓｐｉｂｅｒ株式会社 ブロック共重合体もしくはこれを含有する水分散液、接着剤、塗液、コーティング剤、又は成形体の製造方法

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219487B (hu) 1993-11-19 2001-04-28 Janssen Pharmaceutica Nv. Riszperidont tartalmazó mikrorészecskék, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények és előállításuk
US7192538B2 (en) * 2000-04-12 2007-03-20 Sanko Chemical Industry Co., Ltd. Antistatic composition
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10055857A1 (de) * 2000-11-10 2002-08-22 Creative Peptides Sweden Ab Dj Neue pharmazeutische Depotformulierung
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP2044251B1 (en) 2006-07-14 2019-10-02 NatureWorks LLC Biodegradable aliphatic polyester for use in nonwoven webs
US8710172B2 (en) 2006-07-14 2014-04-29 Kimberly-Clark Worldwide, Inc. Biodegradable aliphatic-aromatic copolyester for use in nonwoven webs
WO2008008074A1 (en) 2006-07-14 2008-01-17 Kimberly-Clark Worldwide, Inc. Biodegradable polyactic acid for use in nonwoven webs
EP2051732A4 (en) * 2006-07-26 2009-10-21 Diamedica Inc DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS AND METHODS THEREFOR
BRPI0721925B1 (pt) 2007-08-22 2018-10-16 Kimberly Clark Co método para formar filamentos biodegradáveis e método para a formação de uma trama não tecida
EP2281080B1 (en) 2008-05-30 2014-03-19 Kimberly-Clark Worldwide, Inc. Nonwoven web comprising polylactic acid fibers
NZ603399A (en) 2010-05-17 2014-09-26 Cebix Inc Pegylated c-peptide
US8461262B2 (en) 2010-12-07 2013-06-11 Kimberly-Clark Worldwide, Inc. Polylactic acid fibers
EP2559435A1 (en) 2011-08-19 2013-02-20 UCB Pharma GmbH Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
HUE032613T2 (en) 2012-06-04 2017-10-30 Diamedica Therapeutics Inc Human tissue kallikrein 1 is glycosylated isoforms
DE102014005782A1 (de) * 2014-04-23 2015-10-29 Martin-Luther-Universität Halle-Wittenberg lnjizierbare und implantierbare Trägersysteme auf Basis von modifizierten Poly(dikarbonsäure-multiol estern) zur kontrollierten Wirkstofffreisetzung
WO2018165551A1 (en) 2017-03-09 2018-09-13 Diamedica Inc. Dosage forms of tissue kallikrein 1

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3378250D1 (en) 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
CH656884A5 (de) 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
US4726076A (en) 1985-06-26 1988-02-23 Francoise Douez Childs garment
JPH0613602B2 (ja) 1987-07-14 1994-02-23 三井東圧化学株式会社 ｄ▲ｌ▼−乳酸−グリコール酸共重合物の製造方法
ES2142787T3 (es) 1988-11-01 2000-05-01 Boehringer Ingelheim Pharma Procedimiento continuo para la preparacion de poliesteres resorbibles y su empleo.
DE69030786T2 (de) 1989-01-27 1998-02-19 Mitsui Toatsu Chemicals Verfahren zur herstellung eines bioverträglichen polyesters
DE4406172C2 (de) * 1994-02-25 2003-10-02 Sanol Arznei Schwarz Gmbh Polyester
JP3307777B2 (ja) * 1994-07-07 2002-07-24 栄修 永田 ハンダ付け方法および装置
US6046882A (en) * 1996-07-11 2000-04-04 International Business Machines Corporation Solder balltape and method for making electrical connection between a head transducer and an electrical lead
US6595408B1 (en) * 1998-10-07 2003-07-22 Micron Technology, Inc. Method of attaching solder balls to BGA package utilizing a tool to pick and dip the solder ball in flux prior to placement
US6336581B1 (en) * 2000-06-19 2002-01-08 International Business Machines Corporation Solder ball connection device and capillary tube thereof
JP2002025025A (ja) * 2000-06-23 2002-01-25 Internatl Business Mach Corp <Ibm> はんだボール接合装置及びはんだボール接合方法
US6589594B1 (en) * 2000-08-31 2003-07-08 Micron Technology, Inc. Method for filling a wafer through-via with a conductive material
JP2002251705A (ja) * 2001-02-16 2002-09-06 Internatl Business Mach Corp <Ibm> はんだボール配設装置、はんだボールリフロー装置、及びはんだボール接合装置。
DE10132567B4 (de) * 2001-07-10 2005-03-31 Pac Tech - Packaging Technologies Gmbh Verfahren und Vorrichtung zum Aufbringen eines Lötmittels auf ein Substrat
JP3753968B2 (ja) * 2001-10-11 2006-03-08 ヒタチグローバルストレージテクノロジーズネザーランドビーブイ 配線一体型サスペンション及びその製造方法
JP4212992B2 (ja) * 2003-09-03 2009-01-21 Ｔｄｋ株式会社 半田ボールの供給方法および供給装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008513524A (ja) * 2004-09-21 2008-05-01 山▲東緑▼叶制▲薬▼有限公司 ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法
WO2024166833A1 (ja) * 2023-02-08 2024-08-15 Ｓｐｉｂｅｒ株式会社 ブロック共重合体もしくはこれを含有する水分散液、接着剤、塗液、コーティング剤、又は成形体の製造方法

Also Published As

Publication number Publication date
ATE271083T1 (de) 2004-07-15
DE10055742B4 (de) 2006-05-11
US7087247B2 (en) 2006-08-08
DE10055742A1 (de) 2002-05-29
AU2002229539A1 (en) 2002-05-21
EP1345979A2 (de) 2003-09-24
WO2002038646A3 (de) 2002-08-01
US20040072986A1 (en) 2004-04-15
EP1345979B1 (de) 2004-07-14
DE50102886D1 (de) 2004-08-19
ES2225636T3 (es) 2005-03-16
WO2002038646A2 (de) 2002-05-16

Similar Documents

Publication Publication Date Title
JP2004514002A (ja) 新規ポリエステル、その製法および前記ポリエステルから製造されるデポー剤
US6197350B1 (en) Method of producing a sustained-release preparation
EP2086567B1 (en) Sustained release formulations comprising very low molecular weight polymers
AU2002212550B2 (en) Delayed-release pharmaceutical formulations containing proinsulin C-peptide
EP2409707B1 (en) Polymer-based sustained release device
NL195056C (nl) Werkwijze voor het bereiden van preparaten die zouten van peptiden met op carboxy eindigende polyesters bevatten.
JP6928695B2 (ja) 改善した安定性を備える医薬組成物
NO162103B (no) Fremgangsm te for fremstilling av et farmasoeytisk p
JP2008273982A (ja) 徐放性製剤の製造法
CN101584867A (zh) 提高生物活性分子传递的方法和组合物
JP2001525826A (ja) 持続放出性遅延型ゲル
CN106667958B (zh) 一种多肽缓释微球制剂及其制备方法
EP4454636A1 (en) Continuous delivery preparation capable of being stably released and preparation method therefor
EP1924242B1 (en) Pharmaceutical composition comprising anastrozole
JPH107583A (ja) 徐放性製剤の製造法
KR102792621B1 (ko) 카그릴린타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 서방성 미립구 제제 및 이의 제조방법
KR102792620B1 (ko) 터제파타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 서방성 미립구 제제 및 이의 제조방법
JPH083055A (ja) 徐放性製剤の製造法
HK1166606B (en) Polymer-based sustained release device

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050107

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060524

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060815

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060822

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070228